Renal replacement therapy and conservative management

Supporting evidence

• Surveillance report

• 2023 exceptional surveillance of renal replacement therapy and conservative management (NICE guideline NG107)

• Other supporting evidence

• Methods (PDF 1.21 MB)

  Published:

  03 October 2018

• Evidence review

• Evidence reviews – October 2018

• A: Initiating RRT (PDF 1.52 MB)

  Published:

  03 October 2018

• B: Modalities of RRT (PDF 6.62 MB)

  Published:

  03 October 2018

• C: Sequencing modalities of RRT (PDF 1.45 MB)

  Published:

  03 October 2018

• D: When to create access formation and/or list for transplantation (PDF 1.94 MB)

  Published:

  03 October 2018

• E: When to assess for RRT (PDF 1.41 MB)

  Published:

  03 October 2018

• F: How to assess people for RRT (PDF 1.32 MB)

  Published:

  03 October 2018

• G: Indicators for transferring/discontinuing RRT (PDF 1.19 MB)

  Published:

  03 October 2018

• H: Symptom recognition (PDF 3.51 MB)

  Published:

  03 October 2018

• I: Dietary management and fluid restriction (PDF 1.56 MB)

  Published:

  03 October 2018

• J: Frequency of review (PDF 1.05 MB)

  Published:

  03 October 2018

• K: Information, education and support (PDF 2.42 MB)

  Published:

  03 October 2018

• L: Decision support interventions (PDF 1.44 MB)

  Published:

  03 October 2018

• M: Coordinating care (PDF 1.42 MB)

  Published:

  03 October 2018

• Economic analysis

• Cost-effectiveness analysis: HDF versus high-flux HD (report) (PDF 2.06 MB)

  Published:

  03 October 2018